Added to YB: 2025-05-29
Pitch date: 2025-04-11
ECOR [bullish]
electroCore, Inc.
-11.5%
current return
Author Info
No bio for this author
Company Info
electroCore, Inc., a bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation (“nVNS”) technology platform in the United States, the United Kingdom, and internationally.
Market Cap
$36.9M
Pitch Price
$5.65
Price Target
13.00 (+165%)
Dividend
N/A
Sector
Health Care Equipment and Supplies
Category
growth
electroCore, Inc. - $ECOR
ECOR: Non-invasive vagus nerve stimulation company with 60% 5Y rev CAGR, 85% margins, approaching profitability. 9 consecutive qtrs of growth, $1.26M Q4 cash burn (vs $4.78M Q1'22). Multiple revenue streams: prescription, consumer (+174% in 2024), military (+85% in 2024). Pending no-cash Quell acquisition. 1.7x 2025 rev, 77-136% upside potential.
Read full article (7 min)